Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Development and Validation of a Blood Test for Screening and Early Detection of Multiple Cancers Based on Circulating Cell-free Nucleic Acid Profiles - Project CADENCE (CAncer Detected Early caN be CurEd)

NCT05633342 is registered in ClinicalTrials.gov with MiRXES Pte Ltd as lead sponsor.

NCT NCT05633342
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05633342 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Development and Validation of a Blood Test for Screening and Early Detection of Multiple Cancers Based on Circulating Cell-free Nucleic Acid Profiles - Project CADENCE (CAncer Detected Early caN be CurEd)
Lead sponsor
MiRXES Pte Ltd
Phase
Observational
Overall status
Unknown status
Start date
July 7, 2022
Completion date
May 31, 2025
Enrollment
15,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, colorectal cancer, esophageal cancer, gastric cancer, liver cancer, ovarian cancer, pancreatic cancer, prostate cancer, thoracic cancer